Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine lozenge trial for oral pain in burning mouth syndrome, Sjögren's syndrome, and oral lichen planus
2011-006196-19Phase 2Terminated
- Sponsor
- Clinical Research Malaysia
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bupivacaine + benzydamine in glossodynia (BMS), Sjögren's syndrome and oral lichen planus (OLP) (2 arms), sponsored by Clinical Research Malaysia. Started Jan 2012; status: terminated.
02
Drugs
bupivacaine + benzydamine
03
Conditions
glossodynia (BMS)Sjögren's syndromeoral lichen planus (OLP)
Beyond the preview
Go deeper on 2011-006196-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006196-19.